CARDINAL HEALTH, INC.

View full entity profile (contributions, contracts, SEC) →

This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.

Lobbying Spend

$49.3M

Filings

283

Firms Hired

Active Period

1999–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	$2,180,000	10	4
2025	$3,070,000	21	5
2024	$1,920,000	12	3
2023	$1,400,000	12	3
2022	$1,830,000	14	4
2021	$3,070,000	17	4
2020	$2,560,000	16	4
2019	$2,730,000	23	5
2018	$2,820,000	18	5
2017	$1,750,000	17	4
2016	$1,190,000	16	5
2015	$2,490,000	9	2
2014	$2,070,000	13	3
2013	$1,930,000	8	2
2012	$2,165,000	8	2
2011	$1,955,000	10	2
2010	$1,295,000	8	2
2009	$935,000	8	2
2008	$930,000	11	3
2007	$1,580,400	8	3
2006	$820,000	2	1
2005	$1,990,000	4	1
2004	$2,580,000	3	1
2003	$1,600,000	4	1
2002	$1,540,000	4	1
2001	$820,000	3	1
2000	$40,000	2	1
1999	$40,000	2	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
CARDINAL HEALTH, INC.	$49,300,400	105
CAPITOL COUNSEL LLC	—	38
CROWELL & MORING LLP	—	40
TWENTY-FIRST CENTURY GROUP, INC.	—	41
BAKER & HOSTETLER LLP	—	18
THORSEN FRENCH ADVOCACY LLC	—	12
ACG ADVOCACY	—	7
BROWNSTEIN HYATT FARBER SCHRECK, LLP	—	6
POWERS PYLES SUTTER & VERVILLE, P.C.	—	7
FIERCE, ISAKOWITZ & BLALOCK	—	4
Polsinelli PC	—	5

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	263
SENATE	261
Health & Human Services, Dept of (HHS)	64
White House Office	30
U.S. Trade Representative (USTR)	28
Federal Emergency Management Agency (FEMA)	26
Defense, Dept of (DOD)	25
Commerce, Dept of (DOC)	20
Centers For Medicare and Medicaid Services (CMS)	17
Executive Office of the President (EOP)	14
Treasury, Dept of	14
Food & Drug Administration (FDA)	12
Homeland Security, Dept of (DHS)	10
Internal Revenue Service (IRS)	9
General Services Administration (GSA)	8
Energy, Dept of	5
State, Dept of (DOS)	5
Centers For Disease Control & Prevention (CDC)	4
Vice President of the U.S.	4
Justice, Dept of (DOJ)	2

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	237
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	99
Pharmacy	Pharmacy	96
Medicare/Medicaid	Medicare/Medicaid	76
Disaster Planning/Emergencies	Disaster Planning/Emergencies	56
Tariff (miscellaneous tariff bills)	Tariff (miscellaneous tariff bills)	49
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	49
Alcohol and Drug Abuse	Alcohol and Drug Abuse	46
Manufacturing	Manufacturing	45
Energy/Nuclear	Energy/Nuclear	43
Budget/Appropriations	Budget/Appropriations	32
Civil Rights/Civil Liberties	Civil Rights/Civil Liberties	24
Trade (domestic/foreign)	Trade (domestic/foreign)	21
Defense	Defense	16
Science/Technology	Science/Technology	15
Veterans	Veterans	10
Homeland Security	Homeland Security	7
Government Issues	Government Issues	4
Food Industry (safety, labeling, etc.)	Food Industry (safety, labeling, etc.)	2
Railroads	Railroads	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 10444119th Congress

Stop Corporate Takeovers of Physicians Act of 2026

2026 · third_quarter · Firm: CARDINAL HEALTH, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164, Ensuring Community Access to Pharmacist Services Act; S. 2426, Equitable Community Access to Pharmacist Services Act, Education around issues facing independent physicians, including, S.3822, the Break Up Big Medicine Act, and H.R. 10444, Stop Corporate Takeovers of Physicians Act of 2026.

Client expense: $400,000 · Firm income: —

Matched citations: H.R. 10444

H.R. 3164119th Congress

Ensuring Community Access to Pharmacist Services Act

2026 · third_quarter · Firm: CARDINAL HEALTH, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164, Ensuring Community Access to Pharmacist Services Act; S. 2426, Equitable Community Access to Pharmacist Services Act, Education around issues facing independent physicians, including, S.3822, the Break Up Big Medicine Act, and H.R. 10444, Stop Corporate Takeovers of Physicians Act of 2026.

Client expense: $400,000 · Firm income: —

Matched citations: H.R. 3164

H.R. 4299119th Congress

Protecting Patient Access to Cancer and Complex Therapies Act

2026 · third_quarter · Firm: CARDINAL HEALTH, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164, Ensuring Community Access to Pharmacist Services Act; S. 2426, Equitable Community Access to Pharmacist Services Act, Education around issues facing independent physicians, including, S.3822, the Break Up Big Medicine Act, and H.R. 10444, Stop Corporate Takeovers of Physicians Act of 2026.

Client expense: $400,000 · Firm income: —

Matched citations: H.R. 4299

H.R. 5031119th Congress

Preserving Patient Access to Long-Term Care Pharmacies Act

2026 · third_quarter · Firm: CARDINAL HEALTH, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164, Ensuring Community Access to Pharmacist Services Act; S. 2426, Equitable Community Access to Pharmacist Services Act, Education around issues facing independent physicians, including, S.3822, the Break Up Big Medicine Act, and H.R. 10444, Stop Corporate Takeovers of Physicians Act of 2026.

Client expense: $400,000 · Firm income: —

Matched citations: H.R. 5031

Show 21 more cited filings

S. 2426119th Congress

Equitable Community Access to Pharmacist Services Act

2026 · third_quarter · Firm: CARDINAL HEALTH, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164, Ensuring Community Access to Pharmacist Services Act; S. 2426, Equitable Community Access to Pharmacist Services Act, Education around issues facing independent physicians, including, S.3822, the Break Up Big Medicine Act, and H.R. 10444, Stop Corporate Takeovers of Physicians Act of 2026.

Client expense: $400,000 · Firm income: —

Matched citations: S. 2426

S. 3159119th Congress

Preserving Patient Access to Long-Term Care Pharmacies Act

2026 · third_quarter · Firm: CARDINAL HEALTH, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164, Ensuring Community Access to Pharmacist Services Act; S. 2426, Equitable Community Access to Pharmacist Services Act, Education around issues facing independent physicians, including, S.3822, the Break Up Big Medicine Act, and H.R. 10444, Stop Corporate Takeovers of Physicians Act of 2026.

Client expense: $400,000 · Firm income: —

Matched citations: S. 3159

S. 3822119th Congress

Break Up Big Medicine Act

2026 · third_quarter · Firm: CARDINAL HEALTH, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164, Ensuring Community Access to Pharmacist Services Act; S. 2426, Equitable Community Access to Pharmacist Services Act, Education around issues facing independent physicians, including, S.3822, the Break Up Big Medicine Act, and H.R. 10444, Stop Corporate Takeovers of Physicians Act of 2026.

Client expense: $400,000 · Firm income: —

Matched citations: S.3822

H.R. 3164119th Congress

Ensuring Community Access to Pharmacist Services Act

2026 · second_quarter · Firm: CARDINAL HEALTH, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, and pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.

Client expense: $460,000 · Firm income: —

Matched citations: H.R. 3164

H.R. 4299119th Congress

Protecting Patient Access to Cancer and Complex Therapies Act

2026 · second_quarter · Firm: CARDINAL HEALTH, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, and pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.

Client expense: $460,000 · Firm income: —

Matched citations: H.R. 4299

H.R. 5031119th Congress

Preserving Patient Access to Long-Term Care Pharmacies Act

2026 · second_quarter · Firm: CARDINAL HEALTH, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, and pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.

Client expense: $460,000 · Firm income: —

Matched citations: H.R. 5031

S. 2426119th Congress

Equitable Community Access to Pharmacist Services Act

2026 · second_quarter · Firm: CARDINAL HEALTH, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, and pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.

Client expense: $460,000 · Firm income: —

Matched citations: S. 2426

S. 3159119th Congress

Preserving Patient Access to Long-Term Care Pharmacies Act

2026 · second_quarter · Firm: CARDINAL HEALTH, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, and pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.

Client expense: $460,000 · Firm income: —

Matched citations: S. 3159

S. 3822119th Congress

Break Up Big Medicine Act

2026 · second_quarter · Firm: CARDINAL HEALTH, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine, and pharmacy services administrative organizations; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home healthcare agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.

Client expense: $460,000 · Firm income: —

Matched citations: S.3822

H.R. 3164119th Congress

Ensuring Community Access to Pharmacist Services Act

2026 · first_quarter · Firm: CARDINAL HEALTH, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home health agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.

Client expense: $1,320,000 · Firm income: —

Matched citations: H.R. 3164

H.R. 4299119th Congress

Protecting Patient Access to Cancer and Complex Therapies Act

2026 · first_quarter · Firm: CARDINAL HEALTH, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home health agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.

Client expense: $1,320,000 · Firm income: —

Matched citations: H.R. 4299

H.R. 5031119th Congress

Preserving Patient Access to Long-Term Care Pharmacies Act

2026 · first_quarter · Firm: CARDINAL HEALTH, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home health agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.

Client expense: $1,320,000 · Firm income: —

Matched citations: H.R. 5031

S. 2426119th Congress

Equitable Community Access to Pharmacist Services Act

2026 · first_quarter · Firm: CARDINAL HEALTH, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home health agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.

Client expense: $1,320,000 · Firm income: —

Matched citations: S. 2426

S. 3159119th Congress

Preserving Patient Access to Long-Term Care Pharmacies Act

2026 · first_quarter · Firm: CARDINAL HEALTH, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home health agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.

Client expense: $1,320,000 · Firm income: —

Matched citations: S. 3159

S. 3822119th Congress

Break Up Big Medicine Act

2026 · first_quarter · Firm: CARDINAL HEALTH, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home health agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act.

Client expense: $1,320,000 · Firm income: —

Matched citations: S.3822

H.R. 4121119th Congress

Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

2026 · first_quarter · Firm: TWENTY-FIRST CENTURY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. H.R. 4121/S. 2256, FY 2026 Agriculture Appropriations; and H.R. 5304/S. 2587, FY 2026 Labor-HHS Appropriations.

Client expense: — · Firm income: $24,000

Matched citations: H.R. 4121

H.R. 5304119th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

2026 · first_quarter · Firm: TWENTY-FIRST CENTURY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. H.R. 4121/S. 2256, FY 2026 Agriculture Appropriations; and H.R. 5304/S. 2587, FY 2026 Labor-HHS Appropriations.

Client expense: — · Firm income: $24,000

Matched citations: H.R. 5304

S. 2256119th Congress

Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

2026 · first_quarter · Firm: TWENTY-FIRST CENTURY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. H.R. 4121/S. 2256, FY 2026 Agriculture Appropriations; and H.R. 5304/S. 2587, FY 2026 Labor-HHS Appropriations.

Client expense: — · Firm income: $24,000

Matched citations: S. 2256

S. 2587119th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

2026 · first_quarter · Firm: TWENTY-FIRST CENTURY GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. H.R. 4121/S. 2256, FY 2026 Agriculture Appropriations; and H.R. 5304/S. 2587, FY 2026 Labor-HHS Appropriations.

Client expense: — · Firm income: $24,000

Matched citations: S. 2587

H.R. 3164119th Congress

Ensuring Community Access to Pharmacist Services Act

2025 · fourth_quarter · Firm: CARDINAL HEALTH, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing, bona fide service fees, Affordable Care Act subsidies, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages (H.R.4299 Protecting Patient Access to Cancer and Complex Therapies Act; H.R.5031 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R.3164/S.2426 Ensuring Community Access to Pharmacist Services Act). Issues related to DMEPOS supplies, competitive bidding, reimbursement to home health agencies, and acute hospital care at home services (H.R.5142 Home Health Stabilization Act of 2025; H.R. 4313 Hospital Inpatient Services Modernization Act).

Client expense: $740,000 · Firm income: —

Matched citations: H.R.3164

H.R. 4299119th Congress

Protecting Patient Access to Cancer and Complex Therapies Act

2025 · fourth_quarter · Firm: CARDINAL HEALTH, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to drug pricing, bona fide service fees, Affordable Care Act subsidies, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages (H.R.4299 Protecting Patient Access to Cancer and Complex Therapies Act; H.R.5031 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R.3164/S.2426 Ensuring Community Access to Pharmacist Services Act). Issues related to DMEPOS supplies, competitive bidding, reimbursement to home health agencies, and acute hospital care at home services (H.R.5142 Home Health Stabilization Act of 2025; H.R. 4313 Hospital Inpatient Services Modernization Act).

Client expense: $740,000 · Firm income: —

Matched citations: H.R.4299

Source: Senate LDA

CARDINAL HEALTH, INC. — Lobbying Disclosure | Poliscope